Azulfidine- (sulfasalazine-) induced hepatic injury.
A patient with Azulfidine-related hepatotoxicity in which prompt recurrence of symptoms, fever skin rash, and laboratory evidence of hepatocellular injury occurred upon readministration of Azulfidine is reported. The clinical and biochemical features support the fact that this was an example of an acquired hypersensitivity reaction to Azulfidine.
D000293:Adolescent; D000410:Alanine Transaminase; D001219:Aspartate Aminotransferases; D001663:Bilirubin / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury; D004342:Drug Hypersensitivity; D005260:Female; D006801:Humans; D012460:Sulfasalazine / Q000009:adverse effects*; D013997:Time Factors
D012460:Sulfasalazine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin